⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Aspire Biopharma Holdings, Inc. Common Stock

$9.49
+0.69 (+7.84%)

Market Capitalization:

$13.31M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Aspire Biopharma Holdings Market Segments

Premarket

+0.00(+0.00%)
Open$9.49
Close$9.49
Low$9.49
Low Change0.00 (0.00%)
High$9.49
High Change+0.00 (+0.00%)
Range$0.00
Volume200
Dollar Volume$1.90K

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$8.88
Close$8.88
Low$8.88
Low Change0.00 (0.00%)
High$8.88
High Change+0.00 (+0.00%)
Range$0.00
Volume2.357K
Dollar Volume$20.93K

Regular Trading Hours Yesterday

+0.13(+1.50%)
Open$8.67
Close$8.80
Low$8.40
Low Change-0.27 (-3.11%)
High$8.85
High Change+0.18 (+2.08%)
Range$0.45
Volume13.273K
Dollar Volume$116.80K

Premarket Yesterday

-0.11(-1.26%)
Open$8.71
Close$8.60
Low$8.60
Low Change-0.11 (-1.26%)
High$8.71
High Change+0.00 (+0.00%)
Range$0.11
Volume416
Dollar Volume$3.58K

Aspire Biopharma Holdings News

There is no current news for this stock at the moment.

Aspire Biopharma Holdings Top Trades

Aspire Biopharma Holdings's top trade so far today returned +0.00%, while the top short trade returned 0.00%.

Aspire Biopharma Holdings Moving Averages

5 Day Moving Average (SMA5)$8.49
10 Day Moving Average (SMA10)$8.48
20 Day Moving Average (SMA20)$8.66
50 Day Moving Average (SMA50)$8.16
100 Day Moving Average (SMA100)$7.09
200 Day Moving Average (SMA200)$4.42

Aspire Biopharma Holdings Statistics

Average Volume (30 Days)33.02K
P/E Ratio (Current)-1.11
EPS (Current)-$7.88
Dividend Yield0.00%
Free Cash Flow-$7.19M
Cash Ratio7.22
Current Ratio7.99
Quick Ratio7.81
Debt to Equity0.00
Enterprise Value$147.31K
EV to EBITDA-0.02
EV to Sales1.51
Price to Book1.05
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales126.10
Return on Assets-0.82%
Return on Equity-0.94%

Aspire Biopharma Holdings Stock Splits

There have been 2 stock splits for Aspire Biopharma Holdings (ASBP). The last reverse stock split occured on May 11, 2026 and reduced the outstanding shares at a ratio of 30:1.

DateTypeRatio
May 11, 2026Reverse30:1
Jan 16, 2026Reverse40:1

Aspire Biopharma Holdings Dividends

There have been no dividends for Aspire Biopharma Holdings (ASBP).